

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.02248031 |
| 2 | drug transmembrane transport (GO:0006855) | 7.74905546 |
| 3 | urate metabolic process (GO:0046415) | 7.30938953 |
| 4 | organic cation transport (GO:0015695) | 6.61194609 |
| 5 | drug transport (GO:0015893) | 6.42554944 |
| 6 | thyroid hormone generation (GO:0006590) | 6.09968573 |
| 7 | lysine catabolic process (GO:0006554) | 6.08795125 |
| 8 | lysine metabolic process (GO:0006553) | 6.08795125 |
| 9 | phosphate ion transport (GO:0006817) | 5.92292831 |
| 10 | positive regulation of respiratory burst (GO:0060267) | 5.75808963 |
| 11 | response to mercury ion (GO:0046689) | 5.71607438 |
| 12 | quaternary ammonium group transport (GO:0015697) | 5.70501003 |
| 13 | negative regulation of complement activation (GO:0045916) | 5.54178029 |
| 14 | thyroid hormone metabolic process (GO:0042403) | 5.46457895 |
| 15 | excretion (GO:0007588) | 5.17593116 |
| 16 | tricarboxylic acid metabolic process (GO:0072350) | 5.05436287 |
| 17 | vitamin D metabolic process (GO:0042359) | 4.88931321 |
| 18 | renal absorption (GO:0070293) | 4.87161761 |
| 19 | glyoxylate metabolic process (GO:0046487) | 4.84174146 |
| 20 | cysteine metabolic process (GO:0006534) | 4.81297088 |
| 21 | phosphate ion homeostasis (GO:0055062) | 4.59284837 |
| 22 | trivalent inorganic anion homeostasis (GO:0072506) | 4.59284837 |
| 23 | phosphate ion transmembrane transport (GO:0035435) | 4.55338188 |
| 24 | negative regulation of protein activation cascade (GO:2000258) | 4.52129573 |
| 25 | peptide catabolic process (GO:0043171) | 4.48768835 |
| 26 | toxin transport (GO:1901998) | 4.45486479 |
| 27 | glycoside metabolic process (GO:0016137) | 4.26834351 |
| 28 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.26750673 |
| 29 | exogenous drug catabolic process (GO:0042738) | 4.23374592 |
| 30 | drug catabolic process (GO:0042737) | 4.23243391 |
| 31 | metanephric nephron tubule development (GO:0072234) | 4.19365210 |
| 32 | metanephric tubule development (GO:0072170) | 4.19365210 |
| 33 | amino-acid betaine transport (GO:0015838) | 4.09535724 |
| 34 | carnitine transport (GO:0015879) | 4.09535724 |
| 35 | branched-chain amino acid metabolic process (GO:0009081) | 4.04888497 |
| 36 | valine metabolic process (GO:0006573) | 4.03477150 |
| 37 | opsonization (GO:0008228) | 4.01265494 |
| 38 | short-chain fatty acid metabolic process (GO:0046459) | 3.96812020 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 3.90912747 |
| 40 | metanephric nephron epithelium development (GO:0072243) | 3.85639694 |
| 41 | glutathione biosynthetic process (GO:0006750) | 3.84283409 |
| 42 | homocysteine metabolic process (GO:0050667) | 3.81178240 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.80346543 |
| 44 | L-phenylalanine metabolic process (GO:0006558) | 3.80346543 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.78335027 |
| 46 | L-phenylalanine catabolic process (GO:0006559) | 3.78335027 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.72339341 |
| 48 | ethanol oxidation (GO:0006069) | 3.67687192 |
| 49 | proline metabolic process (GO:0006560) | 3.64647706 |
| 50 | cellular response to vitamin D (GO:0071305) | 3.63018288 |
| 51 | metanephric epithelium development (GO:0072207) | 3.61424605 |
| 52 | negative regulation of humoral immune response (GO:0002921) | 3.58806352 |
| 53 | cellular modified amino acid catabolic process (GO:0042219) | 3.56727527 |
| 54 | fatty acid beta-oxidation (GO:0006635) | 3.50081896 |
| 55 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.46533259 |
| 56 | regulation of fibrinolysis (GO:0051917) | 3.41749531 |
| 57 | modified amino acid transport (GO:0072337) | 3.39993452 |
| 58 | aromatic amino acid family catabolic process (GO:0009074) | 3.39862847 |
| 59 | 2-oxoglutarate metabolic process (GO:0006103) | 3.38918394 |
| 60 | response to parathyroid hormone (GO:0071107) | 3.36785842 |
| 61 | nephron tubule development (GO:0072080) | 3.32722737 |
| 62 | basement membrane organization (GO:0071711) | 3.30769068 |
| 63 | regulation of protein activation cascade (GO:2000257) | 3.30398682 |
| 64 | cellular response to vitamin (GO:0071295) | 3.28788357 |
| 65 | serine family amino acid catabolic process (GO:0009071) | 3.27916633 |
| 66 | negative regulation of metanephros development (GO:0072217) | 3.26177566 |
| 67 | fatty acid oxidation (GO:0019395) | 3.22405825 |
| 68 | regulation of extracellular matrix disassembly (GO:0010715) | 3.21929431 |
| 69 | branched-chain amino acid catabolic process (GO:0009083) | 3.18061603 |
| 70 | retinol metabolic process (GO:0042572) | 3.17859927 |
| 71 | protein carboxylation (GO:0018214) | 3.17007178 |
| 72 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.17007178 |
| 73 | transcytosis (GO:0045056) | 3.15889013 |
| 74 | positive regulation of digestive system process (GO:0060456) | 3.15514761 |
| 75 | keratan sulfate catabolic process (GO:0042340) | 3.14772563 |
| 76 | lipid oxidation (GO:0034440) | 3.14748470 |
| 77 | NADH metabolic process (GO:0006734) | 3.14313953 |
| 78 | beta-amyloid metabolic process (GO:0050435) | 3.14181424 |
| 79 | peptide biosynthetic process (GO:0043043) | 3.11893842 |
| 80 | nephron tubule morphogenesis (GO:0072078) | 3.11325369 |
| 81 | nephron epithelium morphogenesis (GO:0072088) | 3.11325369 |
| 82 | peptide hormone processing (GO:0016486) | 3.10801096 |
| 83 | regulation of sequestering of triglyceride (GO:0010889) | 3.10737569 |
| 84 | glucocorticoid biosynthetic process (GO:0006704) | 3.09255714 |
| 85 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.08280063 |
| 86 | cellular ketone body metabolic process (GO:0046950) | 3.06597610 |
| 87 | fatty acid homeostasis (GO:0055089) | 3.06589685 |
| 88 | positive regulation of glycolytic process (GO:0045821) | 3.02819441 |
| 89 | potassium ion export (GO:0071435) | 3.01639861 |
| 90 | indole-containing compound catabolic process (GO:0042436) | 3.01048902 |
| 91 | indolalkylamine catabolic process (GO:0046218) | 3.01048902 |
| 92 | tryptophan catabolic process (GO:0006569) | 3.01048902 |
| 93 | fructose metabolic process (GO:0006000) | 2.99308945 |
| 94 | sulfur amino acid catabolic process (GO:0000098) | 2.97915553 |
| 95 | phenylpropanoid metabolic process (GO:0009698) | 2.97215848 |
| 96 | protein retention in ER lumen (GO:0006621) | 2.96177925 |
| 97 | acylglycerol homeostasis (GO:0055090) | 2.95869161 |
| 98 | triglyceride homeostasis (GO:0070328) | 2.95869161 |
| 99 | renal tubule development (GO:0061326) | 2.94778358 |
| 100 | amino-acid betaine metabolic process (GO:0006577) | 2.93852018 |
| 101 | blood coagulation, intrinsic pathway (GO:0007597) | 2.93476266 |
| 102 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.92442223 |
| 103 | ethanol metabolic process (GO:0006067) | 2.92368267 |
| 104 | detection of calcium ion (GO:0005513) | 2.92270446 |
| 105 | tryptophan metabolic process (GO:0006568) | 2.89993510 |
| 106 | response to phenylpropanoid (GO:0080184) | 2.89246004 |
| 107 | response to growth hormone (GO:0060416) | 2.88953338 |
| 108 | detection of molecule of bacterial origin (GO:0032490) | 2.87160779 |
| 109 | oligosaccharide catabolic process (GO:0009313) | 2.87131234 |
| 110 | response to copper ion (GO:0046688) | 2.86574788 |
| 111 | glutathione metabolic process (GO:0006749) | 2.86298334 |
| 112 | primary alcohol metabolic process (GO:0034308) | 2.86288200 |
| 113 | complement activation, alternative pathway (GO:0006957) | 2.86264306 |
| 114 | regulation of guanylate cyclase activity (GO:0031282) | 2.84288560 |
| 115 | hormone catabolic process (GO:0042447) | 2.83149416 |
| 116 | low-density lipoprotein particle clearance (GO:0034383) | 2.81277605 |
| 117 | fatty acid catabolic process (GO:0009062) | 2.80325912 |
| 118 | triglyceride catabolic process (GO:0019433) | 2.78851186 |
| 119 | glucuronate metabolic process (GO:0019585) | 2.78408348 |
| 120 | uronic acid metabolic process (GO:0006063) | 2.78408348 |
| 121 | serine family amino acid metabolic process (GO:0009069) | 2.78262419 |
| 122 | surfactant homeostasis (GO:0043129) | 2.76782657 |
| 123 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.76602516 |
| 124 | response to dietary excess (GO:0002021) | 2.76129547 |
| 125 | renal tubule morphogenesis (GO:0061333) | 2.75736139 |
| 126 | tricarboxylic acid cycle (GO:0006099) | 2.75291105 |
| 127 | carnitine metabolic process (GO:0009437) | 2.75057532 |
| 128 | response to thyroid hormone (GO:0097066) | 2.74922438 |
| 129 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.74753496 |
| 130 | xenobiotic catabolic process (GO:0042178) | 2.73916150 |
| 131 | regulation of lipoprotein metabolic process (GO:0050746) | 2.72045164 |
| 132 | regulation of complement activation (GO:0030449) | 2.71553849 |
| 133 | acetyl-CoA metabolic process (GO:0006084) | 2.71415097 |
| 134 | macroautophagy (GO:0016236) | 2.70831560 |
| 135 | bone resorption (GO:0045453) | 2.70223529 |
| 136 | positive regulation of hormone metabolic process (GO:0032352) | 2.69405435 |
| 137 | ketone body metabolic process (GO:1902224) | 2.67016974 |
| 138 | glycerolipid catabolic process (GO:0046503) | 2.63092296 |
| 139 | toxin metabolic process (GO:0009404) | 2.62776184 |
| 140 | acylglycerol catabolic process (GO:0046464) | 2.61357144 |
| 141 | neutral lipid catabolic process (GO:0046461) | 2.61357144 |
| 142 | fatty acid transmembrane transport (GO:1902001) | 2.60960592 |
| 143 | glycerophospholipid catabolic process (GO:0046475) | 2.60746141 |
| 144 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.55636245 |
| 145 | insulin secretion (GO:0030073) | 2.52999961 |
| 146 | carnitine shuttle (GO:0006853) | 2.51508552 |
| 147 | diacylglycerol metabolic process (GO:0046339) | 2.51048798 |
| 148 | regulation of execution phase of apoptosis (GO:1900117) | 2.49704390 |
| 149 | positive regulation of gluconeogenesis (GO:0045722) | 2.49364319 |
| 150 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.48271938 |
| 151 | regulation of energy homeostasis (GO:2000505) | 2.47501839 |
| 152 | nitric oxide biosynthetic process (GO:0006809) | 2.46810285 |
| 153 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.46633901 |
| 154 | negative regulation of hormone metabolic process (GO:0032351) | 2.44858038 |
| 155 | phospholipid homeostasis (GO:0055091) | 2.43199221 |
| 156 | positive regulation of glomerulus development (GO:0090193) | 2.43080135 |
| 157 | cellular response to gonadotropin stimulus (GO:0071371) | 2.42561902 |
| 158 | lipid particle organization (GO:0034389) | 2.40764180 |
| 159 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.40574839 |
| 160 | biotin metabolic process (GO:0006768) | 2.39797471 |
| 161 | reverse cholesterol transport (GO:0043691) | 2.38582996 |
| 162 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.36453929 |
| 163 | lipid storage (GO:0019915) | 2.35343157 |
| 164 | phenol-containing compound catabolic process (GO:0019336) | 2.35152464 |
| 165 | plasma lipoprotein particle clearance (GO:0034381) | 2.35076130 |
| 166 | epoxygenase P450 pathway (GO:0019373) | 2.34839204 |
| 167 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.34270756 |
| 168 | ovulation from ovarian follicle (GO:0001542) | 2.34125909 |
| 169 | negative regulation of protein autophosphorylation (GO:0031953) | 2.33234549 |
| 170 | polyol transport (GO:0015791) | 2.32307336 |
| 171 | nitric oxide mediated signal transduction (GO:0007263) | 2.30833082 |
| 172 | hormone metabolic process (GO:0042445) | 2.30800353 |
| 173 | nephron tubule formation (GO:0072079) | 2.30368265 |
| 174 | positive regulation of insulin secretion (GO:0032024) | 2.29601730 |
| 175 | oxaloacetate metabolic process (GO:0006107) | 2.26965951 |
| 176 | pattern specification involved in kidney development (GO:0061004) | 2.26938882 |
| 177 | plasma lipoprotein particle remodeling (GO:0034369) | 2.26625868 |
| 178 | macromolecular complex remodeling (GO:0034367) | 2.26625868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.22011348 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.74977635 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.70493141 |
| 4 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.62467706 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.51804644 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.51043812 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.21204375 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.15324803 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.88115674 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.82725818 |
| 11 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.52804317 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.51902558 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.49771632 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.42924022 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30966934 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.11399224 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.10738397 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89780454 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.78556498 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.68120793 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.61931910 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61855348 |
| 23 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.54768459 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51653533 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51125867 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.50882131 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50492092 |
| 28 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.49095248 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47280834 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47241149 |
| 31 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.46641059 |
| 32 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.46641059 |
| 33 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.46013687 |
| 34 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44342210 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39963992 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.36209258 |
| 37 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.35573098 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35287348 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34378630 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33229736 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31962992 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31951446 |
| 43 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29750708 |
| 44 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.26712946 |
| 45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24613348 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24530477 |
| 47 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.24204675 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.23878062 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22366070 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20294150 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19623339 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18939969 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17768110 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16687871 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15604998 |
| 56 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14474711 |
| 57 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14387184 |
| 58 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14180566 |
| 59 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11823501 |
| 60 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.11317453 |
| 61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11225338 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09393307 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09006653 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07009386 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04787515 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04769800 |
| 67 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03086376 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02351842 |
| 69 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02178071 |
| 70 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.01616132 |
| 71 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98083731 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97508498 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97508498 |
| 74 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.97253750 |
| 75 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96489277 |
| 76 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95958569 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95916602 |
| 78 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94713377 |
| 79 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94555402 |
| 80 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94167314 |
| 81 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.92708996 |
| 82 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92423949 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92009791 |
| 84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.91550386 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91402810 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91302087 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91089139 |
| 88 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90098485 |
| 89 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89044087 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88457628 |
| 91 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88400573 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87974554 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87837235 |
| 94 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.85843909 |
| 95 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85287826 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 0.85163513 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84934248 |
| 98 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.84013544 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83533570 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83411815 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82899639 |
| 102 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82815387 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82773360 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82440403 |
| 105 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82347213 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81923428 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81847920 |
| 108 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.81673068 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81067597 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 0.81017009 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80876461 |
| 112 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.80779519 |
| 113 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.80708861 |
| 114 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80681794 |
| 115 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80629784 |
| 116 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80616957 |
| 117 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.80364404 |
| 118 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.80170824 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.80167040 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79946641 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79936158 |
| 122 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79888606 |
| 123 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79602318 |
| 124 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.79272547 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79206691 |
| 126 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79080970 |
| 127 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78351815 |
| 128 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.77987737 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77849196 |
| 130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77757013 |
| 131 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77719716 |
| 132 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.77671606 |
| 133 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77394757 |
| 134 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.76987097 |
| 135 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76021284 |
| 136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.75779424 |
| 137 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74737389 |
| 138 | ATF3_27146783_Chip-Seq_COLON_Human | 0.74320948 |
| 139 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.74305536 |
| 140 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.73203282 |
| 141 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.72882755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 5.05166114 |
| 2 | MP0005360_urolithiasis | 4.89640808 |
| 3 | MP0003011_delayed_dark_adaptation | 4.28685139 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 4.12173773 |
| 5 | MP0001765_abnormal_ion_homeostasis | 3.85124136 |
| 6 | MP0005332_abnormal_amino_acid | 3.74102894 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 3.57456026 |
| 8 | MP0009643_abnormal_urine_homeostasis | 3.50444238 |
| 9 | MP0003195_calcinosis | 3.50028273 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 3.47267313 |
| 11 | MP0001958_emphysema | 3.44998699 |
| 12 | MP0001756_abnormal_urination | 3.18334991 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 3.10288335 |
| 14 | MP0005058_abnormal_lysosome_morphology | 3.04853756 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 3.04062958 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.85503730 |
| 17 | * MP0005636_abnormal_mineral_homeostasis | 2.81445744 |
| 18 | MP0002136_abnormal_kidney_physiology | 2.56413293 |
| 19 | MP0005379_endocrine/exocrine_gland_phen | 2.54883149 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.44582132 |
| 21 | MP0006054_spinal_hemorrhage | 2.19876181 |
| 22 | MP0005377_hearing/vestibular/ear_phenot | 2.12347111 |
| 23 | MP0003878_abnormal_ear_physiology | 2.12347111 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 2.10938058 |
| 25 | MP0000013_abnormal_adipose_tissue | 2.06648969 |
| 26 | MP0002971_abnormal_brown_adipose | 2.02867115 |
| 27 | MP0003252_abnormal_bile_duct | 1.89192874 |
| 28 | MP0000538_abnormal_urinary_bladder | 1.88590256 |
| 29 | MP0002254_reproductive_system_inflammat | 1.87815241 |
| 30 | MP0003868_abnormal_feces_composition | 1.82207106 |
| 31 | MP0004272_abnormal_basement_membrane | 1.71644772 |
| 32 | MP0005365_abnormal_bile_salt | 1.68914856 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.67605620 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.65536326 |
| 35 | MP0005670_abnormal_white_adipose | 1.59346230 |
| 36 | MP0003122_maternal_imprinting | 1.57113386 |
| 37 | MP0003879_abnormal_hair_cell | 1.55655919 |
| 38 | MP0005275_abnormal_skin_tensile | 1.54992400 |
| 39 | MP0000230_abnormal_systemic_arterial | 1.53993196 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.51637644 |
| 41 | MP0004215_abnormal_myocardial_fiber | 1.47980125 |
| 42 | MP0005448_abnormal_energy_balance | 1.45296682 |
| 43 | MP0004885_abnormal_endolymph | 1.44312520 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.40430213 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.37314880 |
| 46 | MP0002896_abnormal_bone_mineralization | 1.35848328 |
| 47 | MP0002168_other_aberrant_phenotype | 1.27214044 |
| 48 | MP0009840_abnormal_foam_cell | 1.25491606 |
| 49 | MP0004130_abnormal_muscle_cell | 1.25223653 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.24637815 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.23597017 |
| 52 | MP0005503_abnormal_tendon_morphology | 1.21569381 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.21409798 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.19680774 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.17993060 |
| 56 | MP0003186_abnormal_redox_activity | 1.16149382 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.15899577 |
| 58 | MP0003279_aneurysm | 1.14428304 |
| 59 | MP0000604_amyloidosis | 1.11166801 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.10774237 |
| 61 | MP0002135_abnormal_kidney_morphology | 1.10074227 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.09623038 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.08587729 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.08307092 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.06766549 |
| 66 | MP0005253_abnormal_eye_physiology | 1.01842890 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.01488414 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.97593142 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 0.96629681 |
| 70 | MP0002972_abnormal_cardiac_muscle | 0.96421713 |
| 71 | MP0009115_abnormal_fat_cell | 0.96187561 |
| 72 | MP0002090_abnormal_vision | 0.94968637 |
| 73 | MP0005375_adipose_tissue_phenotype | 0.94892802 |
| 74 | MP0000639_abnormal_adrenal_gland | 0.94152465 |
| 75 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.92391814 |
| 76 | MP0006138_congestive_heart_failure | 0.91788411 |
| 77 | MP0004085_abnormal_heartbeat | 0.91071058 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.91010053 |
| 79 | MP0001879_abnormal_lymphatic_vessel | 0.90581161 |
| 80 | MP0002163_abnormal_gland_morphology | 0.89236648 |
| 81 | MP0005452_abnormal_adipose_tissue | 0.88516988 |
| 82 | MP0001764_abnormal_homeostasis | 0.87804760 |
| 83 | MP0003690_abnormal_glial_cell | 0.87074776 |
| 84 | MP0001661_extended_life_span | 0.86624014 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.86487801 |
| 86 | MP0000678_abnormal_parathyroid_gland | 0.86410136 |
| 87 | MP0006072_abnormal_retinal_apoptosis | 0.86141626 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86032708 |
| 89 | MP0001542_abnormal_bone_strength | 0.85478901 |
| 90 | MP0002115_abnormal_skeleton_extremities | 0.85180274 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 0.83000773 |
| 92 | MP0002970_abnormal_white_adipose | 0.82277138 |
| 93 | MP0003795_abnormal_bone_structure | 0.81427241 |
| 94 | MP0002928_abnormal_bile_duct | 0.81164215 |
| 95 | MP0002089_abnormal_postnatal_growth/wei | 0.80869942 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.79802547 |
| 97 | MP0005220_abnormal_exocrine_pancreas | 0.79564401 |
| 98 | MP0001666_abnormal_nutrient_absorption | 0.79005214 |
| 99 | MP0003075_altered_response_to | 0.78211313 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.78129563 |
| 101 | MP0003283_abnormal_digestive_organ | 0.77576613 |
| 102 | MP0008004_abnormal_stomach_pH | 0.76548946 |
| 103 | MP0005334_abnormal_fat_pad | 0.74996075 |
| 104 | MP0000163_abnormal_cartilage_morphology | 0.74002422 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.73885429 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.73008486 |
| 107 | MP0001664_abnormal_digestion | 0.73003917 |
| 108 | MP0003137_abnormal_impulse_conducting | 0.72582213 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.72489352 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.71736917 |
| 111 | MP0005165_increased_susceptibility_to | 0.71710116 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.71399766 |
| 113 | MP0002909_abnormal_adrenal_gland | 0.70961896 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.70823279 |
| 115 | MP0000609_abnormal_liver_physiology | 0.69724956 |
| 116 | MP0005164_abnormal_response_to | 0.69181936 |
| 117 | MP0005330_cardiomyopathy | 0.68854865 |
| 118 | MP0003705_abnormal_hypodermis_morpholog | 0.68371128 |
| 119 | MP0005385_cardiovascular_system_phenoty | 0.67474459 |
| 120 | MP0001544_abnormal_cardiovascular_syste | 0.67474459 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.67058566 |
| 122 | MP0004484_altered_response_of | 0.66856553 |
| 123 | MP0000534_abnormal_ureter_morphology | 0.66314612 |
| 124 | MP0001984_abnormal_olfaction | 0.65833626 |
| 125 | MP0009764_decreased_sensitivity_to | 0.65655185 |
| 126 | MP0003959_abnormal_lean_body | 0.65477195 |
| 127 | MP0000747_muscle_weakness | 0.65421547 |
| 128 | MP0001270_distended_abdomen | 0.63571904 |
| 129 | MP0001944_abnormal_pancreas_morphology | 0.63437885 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.62832460 |
| 131 | MP0004858_abnormal_nervous_system | 0.62797129 |
| 132 | MP0005535_abnormal_body_temperature | 0.62661312 |
| 133 | MP0002269_muscular_atrophy | 0.62598135 |
| 134 | MP0000749_muscle_degeneration | 0.62391276 |
| 135 | MP0003329_amyloid_beta_deposits | 0.62255735 |
| 136 | MP0000751_myopathy | 0.62177956 |
| 137 | MP0010368_abnormal_lymphatic_system | 0.61839822 |
| 138 | MP0000343_altered_response_to | 0.61456712 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.58781031 |
| 140 | MP0003953_abnormal_hormone_level | 0.58392154 |
| 141 | MP0005451_abnormal_body_composition | 0.57714796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 6.44164809 |
| 2 | Metabolic alkalosis (HP:0200114) | 6.42670183 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 6.25882537 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 6.12552058 |
| 5 | Gout (HP:0001997) | 5.78937286 |
| 6 | Abnormality of chloride homeostasis (HP:0011422) | 5.73880933 |
| 7 | Polyuria (HP:0000103) | 5.69920810 |
| 8 | Hypomagnesemia (HP:0002917) | 5.50541978 |
| 9 | Abnormal urine output (HP:0012590) | 5.39973580 |
| 10 | Abnormality of renal excretion (HP:0011036) | 5.12404406 |
| 11 | Abnormality of renin-angiotensin system (HP:0000847) | 4.81365128 |
| 12 | Abnormality of magnesium homeostasis (HP:0004921) | 4.77834211 |
| 13 | Proximal tubulopathy (HP:0000114) | 4.71816663 |
| 14 | Abnormal drinking behavior (HP:0030082) | 4.60561229 |
| 15 | Polydipsia (HP:0001959) | 4.60561229 |
| 16 | Goiter (HP:0000853) | 4.51308804 |
| 17 | Hyperaldosteronism (HP:0000859) | 4.48719258 |
| 18 | Renal salt wasting (HP:0000127) | 4.37805824 |
| 19 | Increased purine levels (HP:0004368) | 4.30460750 |
| 20 | Hyperuricemia (HP:0002149) | 4.30460750 |
| 21 | Alkalosis (HP:0001948) | 4.24453055 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.04237254 |
| 23 | Complement deficiency (HP:0004431) | 4.04212499 |
| 24 | Tetany (HP:0001281) | 4.01304532 |
| 25 | Abnormality of purine metabolism (HP:0004352) | 3.99244049 |
| 26 | Hypokalemia (HP:0002900) | 3.96281728 |
| 27 | Hypothermia (HP:0002045) | 3.83830040 |
| 28 | Generalized aminoaciduria (HP:0002909) | 3.82779653 |
| 29 | Hyperglycinuria (HP:0003108) | 3.67318848 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 3.59012055 |
| 31 | Hyperglycemia (HP:0003074) | 3.57419710 |
| 32 | Hypercalciuria (HP:0002150) | 3.50502428 |
| 33 | Ketoacidosis (HP:0001993) | 3.49214684 |
| 34 | Hydroxyprolinuria (HP:0003080) | 3.44879820 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 3.44879820 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 3.42563274 |
| 37 | Increased CSF protein (HP:0002922) | 3.32393260 |
| 38 | Thyroid-stimulating hormone excess (HP:0002925) | 3.30082338 |
| 39 | Congenital sensorineural hearing impairment (HP:0008527) | 3.28016634 |
| 40 | Abnormality of potassium homeostasis (HP:0011042) | 3.27703531 |
| 41 | Decreased circulating renin level (HP:0003351) | 3.22408046 |
| 42 | Xanthomatosis (HP:0000991) | 3.12523104 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 3.08473155 |
| 44 | Glycosuria (HP:0003076) | 3.08473155 |
| 45 | Hyperthyroidism (HP:0000836) | 3.08088243 |
| 46 | Abnormality of complement system (HP:0005339) | 3.04981367 |
| 47 | Renal tubular acidosis (HP:0001947) | 2.96647071 |
| 48 | Dysostosis multiplex (HP:0000943) | 2.96257409 |
| 49 | Glomerulonephritis (HP:0000099) | 2.94269924 |
| 50 | Joint hemorrhage (HP:0005261) | 2.91460399 |
| 51 | Congenital malformation of the right heart (HP:0011723) | 2.89117053 |
| 52 | Double outlet right ventricle (HP:0001719) | 2.89117053 |
| 53 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.81067858 |
| 54 | Ketosis (HP:0001946) | 2.77498803 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 2.76878881 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.76878881 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.75788306 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.75788306 |
| 59 | Large for gestational age (HP:0001520) | 2.69581248 |
| 60 | Spondylolisthesis (HP:0003302) | 2.68170821 |
| 61 | Hyperlipoproteinemia (HP:0010980) | 2.68122322 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67988181 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.66145272 |
| 64 | Hyperphosphaturia (HP:0003109) | 2.64703762 |
| 65 | Nephrolithiasis (HP:0000787) | 2.56923310 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56489491 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56489491 |
| 68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56489491 |
| 69 | Abnormality of sodium homeostasis (HP:0010931) | 2.54733417 |
| 70 | Abnormality of vitamin metabolism (HP:0100508) | 2.54089790 |
| 71 | Oligomenorrhea (HP:0000876) | 2.48607625 |
| 72 | Malnutrition (HP:0004395) | 2.48496003 |
| 73 | Delayed epiphyseal ossification (HP:0002663) | 2.47195657 |
| 74 | Abnormal urine phosphate concentration (HP:0012599) | 2.47009066 |
| 75 | Nephrocalcinosis (HP:0000121) | 2.46158785 |
| 76 | Deep venous thrombosis (HP:0002625) | 2.44594027 |
| 77 | Hypoglycemic seizures (HP:0002173) | 2.44546857 |
| 78 | Syncope (HP:0001279) | 2.44384566 |
| 79 | Persistence of primary teeth (HP:0006335) | 2.43558531 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.42373200 |
| 81 | Hypophosphatemia (HP:0002148) | 2.41273764 |
| 82 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.38901777 |
| 83 | Mitral stenosis (HP:0001718) | 2.37854952 |
| 84 | Adrenal overactivity (HP:0002717) | 2.36729350 |
| 85 | Hyponatremia (HP:0002902) | 2.34844898 |
| 86 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.34492807 |
| 87 | Metaphyseal cupping (HP:0003021) | 2.32000361 |
| 88 | Thin bony cortex (HP:0002753) | 2.31983338 |
| 89 | Premature rupture of membranes (HP:0001788) | 2.29201551 |
| 90 | Hypobetalipoproteinemia (HP:0003563) | 2.25089675 |
| 91 | Cervical subluxation (HP:0003308) | 2.21581960 |
| 92 | Hypoglycemic coma (HP:0001325) | 2.21127312 |
| 93 | Insulin resistance (HP:0000855) | 2.19849014 |
| 94 | Chondrocalcinosis (HP:0000934) | 2.18899643 |
| 95 | Skin nodule (HP:0200036) | 2.15703701 |
| 96 | Abnormality of vitamin B metabolism (HP:0004340) | 2.14979686 |
| 97 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.13802889 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12981883 |
| 99 | Epidermoid cyst (HP:0200040) | 2.11171181 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 2.10793380 |
| 101 | Intestinal atresia (HP:0011100) | 2.10389987 |
| 102 | Widely patent fontanelles and sutures (HP:0004492) | 2.07452733 |
| 103 | Prolonged QT interval (HP:0001657) | 2.07107857 |
| 104 | Aortic dissection (HP:0002647) | 2.06772303 |
| 105 | Vomiting (HP:0002013) | 2.03875446 |
| 106 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.03304089 |
| 107 | Vascular calcification (HP:0004934) | 2.03235729 |
| 108 | Abnormality of Sharpey fibers (HP:0100685) | 2.02385974 |
| 109 | Striae distensae (HP:0001065) | 2.01672962 |
| 110 | Rickets (HP:0002748) | 2.01577340 |
| 111 | Nuclear cataract (HP:0100018) | 2.01130270 |
| 112 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 2.00310702 |
| 113 | Growth hormone excess (HP:0000845) | 2.00304186 |
| 114 | Dehydration (HP:0001944) | 2.00000334 |
| 115 | Enlarged penis (HP:0000040) | 1.98880174 |
| 116 | Progressive neurologic deterioration (HP:0002344) | 1.98290590 |
| 117 | Postural tremor (HP:0002174) | 1.97339261 |
| 118 | Palpitations (HP:0001962) | 1.96709846 |
| 119 | Aortic aneurysm (HP:0004942) | 1.96563750 |
| 120 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.96329391 |
| 121 | Cardiovascular calcification (HP:0011915) | 1.95383034 |
| 122 | Hypolipoproteinemia (HP:0010981) | 1.95320585 |
| 123 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93572176 |
| 124 | Pigmentary retinal degeneration (HP:0001146) | 1.93523948 |
| 125 | Atrial fibrillation (HP:0005110) | 1.92190415 |
| 126 | Bradycardia (HP:0001662) | 1.91594961 |
| 127 | Nausea (HP:0002018) | 1.89206496 |
| 128 | Abnormal EKG (HP:0003115) | 1.88441530 |
| 129 | Hypoalphalipoproteinemia (HP:0003233) | 1.88095008 |
| 130 | Hyperkalemia (HP:0002153) | 1.87871755 |
| 131 | Arterial tortuosity (HP:0005116) | 1.87633206 |
| 132 | Abnormality of renal resorption (HP:0011038) | 1.87052985 |
| 133 | Thyroid carcinoma (HP:0002890) | 1.86810208 |
| 134 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86753354 |
| 135 | Tubulointerstitial fibrosis (HP:0005576) | 1.85932565 |
| 136 | Enlarged kidneys (HP:0000105) | 1.84917304 |
| 137 | Lymphangioma (HP:0100764) | 1.83857575 |
| 138 | Acanthosis nigricans (HP:0000956) | 1.83093900 |
| 139 | Late onset (HP:0003584) | 1.83057767 |
| 140 | Dicarboxylic aciduria (HP:0003215) | 1.82938607 |
| 141 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82938607 |
| 142 | Testicular neoplasm (HP:0010788) | 1.81718227 |
| 143 | Bundle branch block (HP:0011710) | 1.81641159 |
| 144 | Axonal loss (HP:0003447) | 1.81471808 |
| 145 | Bone cyst (HP:0012062) | 1.80376089 |
| 146 | Hypokinesia (HP:0002375) | 1.79743644 |
| 147 | Cerebral aneurysm (HP:0004944) | 1.79134049 |
| 148 | Hypotension (HP:0002615) | 1.78770287 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78067358 |
| 150 | Vascular tortuosity (HP:0004948) | 1.77195759 |
| 151 | Hyperammonemia (HP:0001987) | 1.76082142 |
| 152 | Facial shape deformation (HP:0011334) | 1.75278443 |
| 153 | Potter facies (HP:0002009) | 1.75278443 |
| 154 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75041621 |
| 155 | Metabolic acidosis (HP:0001942) | 1.73182005 |
| 156 | Hyperglycinemia (HP:0002154) | 1.72557580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 8.08376095 |
| 2 | WNK3 | 7.62451494 |
| 3 | OXSR1 | 4.91018432 |
| 4 | GRK1 | 3.09381386 |
| 5 | STK39 | 2.99211676 |
| 6 | PHKG2 | 2.77717908 |
| 7 | PHKG1 | 2.77717908 |
| 8 | TGFBR2 | 2.69720498 |
| 9 | MAPK15 | 2.49367646 |
| 10 | MYLK | 2.40464543 |
| 11 | BCKDK | 2.33155244 |
| 12 | STK38L | 2.31232371 |
| 13 | PIK3CG | 2.28352918 |
| 14 | ERN1 | 2.23970553 |
| 15 | FGFR3 | 2.13463057 |
| 16 | MAP2K6 | 2.00958034 |
| 17 | FGFR2 | 1.95099577 |
| 18 | WNK1 | 1.82607135 |
| 19 | NLK | 1.77866145 |
| 20 | DAPK2 | 1.64046560 |
| 21 | AKT3 | 1.60649451 |
| 22 | PDK2 | 1.56478482 |
| 23 | SGK494 | 1.44364781 |
| 24 | SGK223 | 1.44364781 |
| 25 | NTRK3 | 1.42884200 |
| 26 | STK24 | 1.41071328 |
| 27 | TRIB3 | 1.40629541 |
| 28 | PDK3 | 1.36164051 |
| 29 | PDK4 | 1.36164051 |
| 30 | PRKCE | 1.36055652 |
| 31 | MAP4K2 | 1.33773177 |
| 32 | INSRR | 1.30844980 |
| 33 | MST1R | 1.25332398 |
| 34 | STK38 | 1.25309972 |
| 35 | TTN | 1.24955986 |
| 36 | FGFR4 | 1.22866218 |
| 37 | TIE1 | 1.21390938 |
| 38 | EPHB1 | 1.19826485 |
| 39 | CAMK2D | 1.17981203 |
| 40 | PDGFRA | 1.14376860 |
| 41 | FRK | 1.07901446 |
| 42 | PAK4 | 0.98400279 |
| 43 | STK3 | 0.96962054 |
| 44 | HIPK2 | 0.95897718 |
| 45 | FER | 0.94035475 |
| 46 | LRRK2 | 0.93231531 |
| 47 | PTK2 | 0.91641626 |
| 48 | MAP3K12 | 0.90448273 |
| 49 | NEK1 | 0.88636223 |
| 50 | MAP3K3 | 0.88301922 |
| 51 | MAPKAPK3 | 0.82755723 |
| 52 | ADRBK2 | 0.82221384 |
| 53 | UHMK1 | 0.82098588 |
| 54 | PTK6 | 0.78985798 |
| 55 | GSK3A | 0.78208039 |
| 56 | PRKD3 | 0.77095812 |
| 57 | YES1 | 0.73333908 |
| 58 | TESK1 | 0.72612968 |
| 59 | EPHA2 | 0.71976948 |
| 60 | PAK3 | 0.71916929 |
| 61 | MAP3K4 | 0.70486197 |
| 62 | TAOK3 | 0.70035207 |
| 63 | EPHB2 | 0.68124777 |
| 64 | MET | 0.67883156 |
| 65 | DYRK1B | 0.67833480 |
| 66 | PDPK1 | 0.66095423 |
| 67 | RIPK1 | 0.65057013 |
| 68 | CAMK1 | 0.64026394 |
| 69 | CSNK1G1 | 0.62924888 |
| 70 | MAP3K2 | 0.62457543 |
| 71 | SGK3 | 0.62342094 |
| 72 | PRKACG | 0.60740356 |
| 73 | EPHA3 | 0.58429647 |
| 74 | MAP3K7 | 0.58249402 |
| 75 | MAP3K6 | 0.57406531 |
| 76 | PRKG1 | 0.56816198 |
| 77 | PRKCG | 0.54793187 |
| 78 | SGK2 | 0.53803790 |
| 79 | NTRK1 | 0.52687778 |
| 80 | JAK1 | 0.51750573 |
| 81 | PRKD2 | 0.50689036 |
| 82 | PRKACA | 0.50498882 |
| 83 | LATS1 | 0.49999853 |
| 84 | AKT2 | 0.49710296 |
| 85 | STK4 | 0.49161999 |
| 86 | PINK1 | 0.48739488 |
| 87 | ADRBK1 | 0.48661419 |
| 88 | DDR2 | 0.48523663 |
| 89 | PTK2B | 0.48006518 |
| 90 | NEK9 | 0.46538985 |
| 91 | CAMK2G | 0.45298966 |
| 92 | IRAK1 | 0.45292407 |
| 93 | PIK3CA | 0.44802949 |
| 94 | ROCK1 | 0.44432046 |
| 95 | OBSCN | 0.43798369 |
| 96 | CDC42BPA | 0.43530800 |
| 97 | PRKACB | 0.43527352 |
| 98 | KDR | 0.41815487 |
| 99 | PAK2 | 0.40649318 |
| 100 | CSNK1G2 | 0.40090921 |
| 101 | MAP2K2 | 0.39935821 |
| 102 | PRKCH | 0.39932298 |
| 103 | IRAK3 | 0.39632902 |
| 104 | CSNK1A1 | 0.37718028 |
| 105 | SGK1 | 0.37661979 |
| 106 | BMX | 0.37159588 |
| 107 | MAP2K3 | 0.36933973 |
| 108 | ABL2 | 0.35894860 |
| 109 | MST4 | 0.35790251 |
| 110 | LIMK1 | 0.34263595 |
| 111 | RET | 0.34201148 |
| 112 | PRKAA1 | 0.34192977 |
| 113 | CAMK2A | 0.33392070 |
| 114 | MAPK12 | 0.33061682 |
| 115 | DMPK | 0.32590714 |
| 116 | PKN2 | 0.30786159 |
| 117 | PDK1 | 0.30492159 |
| 118 | CSK | 0.30161666 |
| 119 | LMTK2 | 0.27980760 |
| 120 | MAP3K1 | 0.25793134 |
| 121 | PRKAA2 | 0.25562679 |
| 122 | MARK3 | 0.23177073 |
| 123 | PRKD1 | 0.23054199 |
| 124 | MTOR | 0.22967013 |
| 125 | PRKCI | 0.22413742 |
| 126 | FGFR1 | 0.21934311 |
| 127 | MAP2K1 | 0.21732892 |
| 128 | DAPK3 | 0.20978516 |
| 129 | SCYL2 | 0.19343703 |
| 130 | ILK | 0.18719222 |
| 131 | PRKG2 | 0.18152660 |
| 132 | SRC | 0.16908188 |
| 133 | ROCK2 | 0.16502587 |
| 134 | KSR2 | 0.16419558 |
| 135 | SIK1 | 0.15813477 |
| 136 | MAP3K10 | 0.15356513 |
| 137 | TRPM7 | 0.14899994 |
| 138 | JAK2 | 0.14635242 |
| 139 | MAPK11 | 0.14265959 |
| 140 | ZAP70 | 0.13750673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.46924224 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.97333703 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95895549 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74593934 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.71060216 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.68243596 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.66335367 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.62440066 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56815475 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.51991781 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.40310929 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.37780166 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.33023886 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17956729 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.15343574 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10964880 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.03518995 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.99501981 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.99488525 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85814398 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.79409110 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.77323367 |
| 23 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.74497679 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.73780149 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.58030707 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55169083 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52755160 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.52551003 |
| 29 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.50309416 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.44723704 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.40603097 |
| 32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.39679622 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.38467341 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36871898 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.34705629 |
| 36 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.33310462 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30459559 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29916905 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28479728 |
| 40 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.22968902 |
| 41 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22267211 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20387474 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.20077804 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17378513 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 1.16066422 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 1.15659645 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08876988 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08398639 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98914004 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.91551287 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 0.91471814 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89457183 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81603842 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80360630 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79890995 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78462930 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77382644 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77249985 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76982381 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75526988 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75375216 |
| 62 | Protein export_Homo sapiens_hsa03060 | 0.74870488 |
| 63 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74773201 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74202523 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74126395 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73959250 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73882476 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72802956 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72331757 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.71283734 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68707363 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66472249 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63780224 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61639798 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60788933 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59895628 |
| 77 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58524575 |
| 78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58494992 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56150078 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55417921 |
| 81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54229034 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53766963 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51950582 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48107613 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45564865 |
| 86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45041456 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44667610 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44589045 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44117352 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43470000 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43187892 |
| 92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42872116 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41893123 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41516986 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.40620829 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.40084895 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38759437 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38757413 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37766034 |
| 100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36826476 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.35382179 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35129343 |
| 103 | GABAergic synapse_Homo sapiens_hsa04727 | 0.34747559 |
| 104 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34119333 |
| 105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33613889 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33485536 |
| 107 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31858687 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31657582 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28471805 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27755667 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.27568855 |
| 112 | Retinol metabolism_Homo sapiens_hsa00830 | 0.25453540 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.23600956 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21181169 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.18297462 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17706869 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.17642162 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16623116 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16461555 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.16311716 |
| 121 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.15408210 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15091539 |
| 123 | Alzheimers disease_Homo sapiens_hsa05010 | 0.14584269 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14434987 |

